Stocks · Healthcare · Medical - Healthcare Information Services
BrightSpring Health Services, Inc. Common Stock BTSG
$62.00 +2.90% Close, Oct 5, 2026 · NASDAQ · Market cap $11.82B
Strong growthStrong trendInexpensive vs sector
Next earnings report: Oct 30, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $1.34, up 334.4% year over year.
- Over the past year the stock returned +115.7%, ahead of the S&P 500 by 99.9 percentage points.
- The stock is in an uptrend: above its 200-day average for 294 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 33%
- EPS growth (TTM, YoY)Top 4%
- FCF growth (TTM, YoY)Top 15%
- Revenue growth, 3-year CAGRTop 32%
- Revenue growth accelerationBottom 40%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 17%
- Gross marginBottom 11%
- Operating marginTop 37%
- Cash conversion (OCF / net income)Top 42%
- Accruals (lower is better)Bottom 31%
- Net debt / EBITDA (lower is better)Bottom 31%
- Interest coverTop 32%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 23%
- Free-cash-flow yieldTop 24%
- EBITDA / enterprise valueTop 24%
- Sales / enterprise valueTop 9%
- P/E vs own 5-year history (lower is better)Top 38%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 15%
- 6-month returnTop 26%
- 1-year return vs S&P 500Top 13%
- Distance from 52-week highTop 27%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 31%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 33%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 44%
- Maximum drawdown, 3 yearsTop 9%
- Beta vs S&P 500 (lower is better)Bottom 47%
- Net debt / EBITDA (lower is better)Bottom 31%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 21.0% | 19.9% | ↓ |
| EPS growth (YoY) | 287.8% | 334.4% | ↑ |
| Gross margin | 12.9% | 12.4% | ↓ |
| Operating margin | 2.0% | 3.3% | ↑ |
| FCF margin | 1.6% | 2.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 19.9% | 21.0% | ↓ | Top 33% |
| EPS growth (TTM, YoY) | 334.4% | 287.8% | ↑ | Top 4% |
| Gross margin | 12.4% | 12.9% | ↓ | Bottom 11% |
| Operating margin | 3.3% | 2.0% | ↑ | Top 37% |
| Net margin | 2.0% | 0.5% | ↑ | — |
| Free-cash-flow margin | 2.8% | 1.6% | ↑ | — |
| Return on invested capital | 8.9% | — | Top 17% | |
| Revenue growth, 3-year CAGR | 18.7% | — | Top 32% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.72×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +2.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 2.88×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 3.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 1.02%
- Shareholder yield
- 1.02%
- Share count change, 1 year
- +1.8%
- Share count change, 3-year CAGR
- +8.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 31, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +14.7%
- Average 2-day reaction, last 8
- +2.0%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $77.50
- Target vs current price
- +25.0%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 31, 2026 | +13.6% | -18.1% | -16.8% | -16.4% | — |
| May 1, 2026 | +34.5% | +9.6% | +10.4% | +28.6% | +51.1% |
| Feb 27, 2026 | -2.9% | +3.2% | +4.1% | +6.7% | +45.8% |
| Oct 31, 2025 | +13.9% | +0.8% | -0.6% | +10.3% | +20.6% |
| Aug 1, 2025 | +15.8% | -4.9% | -0.9% | +14.9% | +62.4% |
| May 2, 2025 | +137.5% | +16.6% | +25.8% | +33.0% | +12.3% |
| Mar 6, 2025 | +15.8% | -6.3% | -3.4% | -1.1% | +29.5% |
| Nov 1, 2024 | -38.9% | +15.2% | +26.4% | +28.9% | +61.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 31, 2026 | $0.45 | $0.40 | +13.6% | $3.87B |
| May 1, 2026 | $0.39 | $0.29 | +34.5% | $3.61B |
| Feb 27, 2026 | $0.33 | $0.34 | -2.9% | $3.55B |
| Oct 31, 2025 | $0.30 | $0.26 | +13.9% | $3.33B |
| Aug 1, 2025 | $0.22 | $0.19 | +15.8% | $3.15B |
| May 2, 2025 | $0.19 | $0.08 | +137.5% | $2.88B |
| Mar 6, 2025 | $0.22 | $0.19 | +15.8% | $3.05B |
| Nov 1, 2024 | $0.11 | $0.18 | -38.9% | $2.91B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 46.3× | 48.8× | 33th | Top 23% |
| P/E (forward) | 34.1× | — | — | — |
| EV / EBITDA | 21.4× | — | — | Top 24% |
| EV / Sales | 0.95× | — | — | Top 9% |
| Free-cash-flow yield | 3.40% | — | — | Top 24% |
| Earnings yield | 2.16% | — | — | Top 23% |
P/E over the past five years
Range 28.5× – 74.9× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +115.7%
- Earnings per share growth (TTM)
- +334.4%
- Change in P/E multiple
- -30.0%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- Days above the 200-day average
- 294
- 50-day average slope (20 days)
- -7.4%
- 200-day average slope (20 days)
- +4.6%
- Distance from 50-day average
- +2.8%
- Distance from 200-day average
- +18.3%
- RSI (14)
- 60.5
- Relative volume
- 1.22×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 59.5%
- Volatility vs own 5-year history
- 99th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.15
- Correlation with S&P 500
- 0.39
- Current drawdown from 1-year high
- -15.0%
- Maximum drawdown, 3 years
- -35.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 30, 2025 | Apr 21, 2025 | -35.6% | 55 days | 19 days (May 16, 2025) |
| Feb 7, 2024 | Mar 14, 2024 | -28.4% | 25 days | 35 days (May 3, 2024) |
| Jul 24, 2026 | Sep 29, 2026 | -23.6% | 46 days | Not yet recovered |
| May 16, 2025 | Aug 4, 2025 | -20.8% | 53 days | 14 days (Aug 22, 2025) |
| Nov 11, 2024 | Dec 30, 2024 | -15.1% | 33 days | 13 days (Jan 21, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $11.82B
- P/E (TTM)
- 46.3
- EPS, diluted (TTM)
- $1.34
- Revenue (TTM)
- $14.37B
- 52-week range
- $27.11 – $73.75
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $6.70B | $7.72B | $8.83B | $11.27B | $12.91B |
| Gross profit | $1.25B | $1.35B | $1.43B | $1.59B | $1.52B |
| Operating income | $234.2M | $187.8M | $147.2M | $206.4M | $295.3M |
| Net income | $49.8M | -$53.9M | -$154.6M | -$18.1M | $190.7M |
| EPS (diluted) | $0.29 | -$0.31 | -$0.90 | -$0.09 | $0.87 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.91B | $3.05B | $2.88B | $3.15B | $3.33B | $3.55B | $3.61B | $3.87B |
| Net income | -$8.2M | $16.0M | $29.5M | $28.2M | $55.8M | $77.1M | $74.4M | $86.7M |
| EPS (diluted) | -$0.04 | $0.08 | $0.14 | $0.13 | $0.26 | $0.35 | $0.34 | $0.39 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $270.2M | -$4.7M | $210.8M | $23.8M | $490.2M |
| Capital expenditure | -$59.3M | -$70.1M | -$73.5M | -$80.9M | -$95.5M |
| Free cash flow | $210.9M | -$74.8M | $137.3M | -$57.1M | $394.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $12.4M | $0 | -$650,000 | $1.04B | -$17.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $550.4M
- Total assets
- $5.99B
- Total liabilities
- $3.93B
- Total debt
- $2.39B
- Net debt
- $1.84B
- Shareholders’ equity
- $2.05B
As of Jun 30, 2026 (filed Jul 31, 2026).
Short interest
- Shares sold short
- 10,183,689
- Days to cover
- 4.63
- Change vs previous report
- +0.4%
FINRA short interest, settlement date Sep 15, 2026.